...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Zenith share issue
5
Nov 13, 2017 11:10PM
2
Nov 14, 2017 12:34PM
7
Nov 14, 2017 12:47PM
6
Nov 14, 2017 01:11PM
3
Nov 15, 2017 11:07AM

In the Zenith last webcast last month in October  DM specifically stated we will be issuing $10 mil very shortly, not sure if that was $10 mil USd or Canadian, If he didn't know it was 100% happening , I doubt he would have stated that way or he would  have stated we may issue $10 mil

My question is whether it will be priced out at the enterprise value they stated in the pressy, which was $350 mil USd which i beleive works out to $3 USD per share if i am correct,  I ahve my doubts and would love to be surprised 

6
Nov 15, 2017 02:41PM
6
Nov 15, 2017 03:30PM
Share
New Message
Please login to post a reply